Back to User profile » Dr Isabel Kloer
Papers published by Dr Isabel Kloer:
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
No Influence on Cardiac Arrhythmia or Heart Rate from Long-Term Treatment with Tiotropium/Olodaterol versus Monocomponents by Holter ECG Analysis in Patients with Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1945-1953
Published Date: 10 August 2020
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
![Thematic Series](assets/img/article_icons/thematic-series.png)
A Post Hoc Holter ECG Analysis of Olodaterol and Formoterol in Moderate-to-Very-Severe COPD
Andreas S, Bothner U, de la Hoz A, Kloer I, Trampisch M, Alter P
International Journal of Chronic Obstructive Pulmonary Disease 2020, 15:1955-1965
Published Date: 10 August 2020
![Video](assets/img/article_icons/video.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
![Plain language summary](assets/img/article_icons/plain-language.png)
Long-term safety of tiotropium/olodaterol Respimat® in patients with moderate-to-very severe COPD and renal impairment in the TONADO® studies
![](assets/img/youtube_social_icon_dark.png)
![](http://img.youtube.com/vi/fBn38LINnwE/1.jpg)
LaForce C, Derom E, Bothner U, Kloer IM, Trampisch M, Buhl R
International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1819-1831
Published Date: 1 June 2018